SIRT6 and atherosclerosis: Patients with diabetic atherosclerosis showed higher endothelial SIRT6 in plaques following administration of glucagon-like peptide-1 (GLP-1) receptor agonists [82], revealing endothelial SIRT6 as a curative effect index and target for atherosclerosis treatment.